Response in the placebo group in randomized controlled trials for moderate-to-severe psoriasis

被引:0
|
作者
Afach, Sivem [1 ]
Le Cleach, Laurence [1 ,2 ]
Sbidian, Emilie [1 ,2 ]
机构
[1] Univ Paris Est Creteil, UPEC EpiDermE EA, Creteil, France
[2] UPEC, Hop Univ Henri Mondor, AP HP, Dept Dermatol, Creteil, France
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
32102
引用
收藏
页码:AB103 / AB103
页数:1
相关论文
共 50 条
  • [11] Efficacy and safety of tofacitinib for moderate-to-severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials
    Kuo, C. -M.
    Tung, T. -H.
    Wang, S. -H.
    Chi, C. -C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (03) : 355 - 362
  • [12] Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials
    Schmitt, J.
    Zhang, Z.
    Wozel, G.
    Meurer, M.
    Kirch, W.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (03) : 513 - 526
  • [13] Sex Differences in Moderate-to-Severe Traumatic Brain Injury Randomized Controlled Trials
    Flores-Sandoval, Cecilia
    MacKenzie, Heather M.
    Bateman, Emma A.
    Sequeira, Keith
    Bayley, Mark
    Teasell, Robert
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2024,
  • [14] Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial
    Bissonnette, R.
    Iversen, L.
    Sofen, H.
    Griffiths, C. E. M.
    Foley, P.
    Romiti, R.
    Bachinsky, M.
    Rottinghaus, S. T.
    Tan, H.
    Proulx, J.
    Valdez, H.
    Gupta, P.
    Mallbris, L.
    Wolk, R.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 172 (05) : 1395 - 1406
  • [15] Placebo Response in Phase 3 Trials of Systemic Therapies for Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Meta-Analysis
    Ambikaibalan, Danni
    Quaade, Anna Sophie
    Halling, Anne-Sofie
    Thyssen, Jacob P.
    Egeberg, Alexander
    DERMATOLOGY, 2021, 237 (02) : 158 - 165
  • [16] Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study
    Bissonnette, R.
    Haydey, R.
    Rosoph, L. A.
    Lynde, C. W.
    Bukhalo, M.
    Fowler, J. F.
    Delorme, I.
    Gagne-Henley, A.
    Gooderham, M.
    Poulin, Y.
    Barber, K.
    Jenkin, P.
    Landells, I.
    Pariser, D. M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (03) : 403 - 410
  • [17] A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S)
    Gelfand, Joel M.
    Shin, Daniel B.
    Duffin, Kristina Callis
    Armstrong, April W.
    Blauvelt, Andrew
    Tyring, Stephen K.
    Menter, Alan
    Gottlieb, Scott
    Lockshin, Benjamin N.
    Simpson, Eric L.
    Kianifard, Farid
    Sarkar, Rajendra Prasad
    Muscianisi, Elisa
    Steadman, Jennifer
    Ahlman, Mark A.
    Playford, Martin P.
    Joshi, Aditya A.
    Dey, Amit K.
    Werner, Thomas J.
    Alavi, Abass
    Mehta, Nehal N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (09) : 1784 - +
  • [18] Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
    Egeberg, Alexander
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (21): : 2101 - 2102
  • [19] Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
    Gordon, K. B.
    Blauvelt, A.
    Papp, K. A.
    Langley, R. G.
    Luger, T.
    Ohtsuki, M.
    Reich, K.
    Amato, D.
    Ball, S. G.
    Braun, D. K.
    Cameron, G. S.
    Erickson, J.
    Konrad, R. J.
    Muram, T. M.
    Nickoloff, B. J.
    Osuntokun, O. O.
    Secrest, R. J.
    Zhao, F.
    Mallbris, L.
    Leonardi, C. L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (04): : 345 - 356
  • [20] Early identification of response with methotrexate for moderate-to-severe psoriasis
    Gordon, K.
    Sundaram, M.
    Arunajadai, S.
    Xie, M.
    Signorovitch, J.
    Betts, K.
    Okun, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (06) : E153 - E153